249 related articles for article (PubMed ID: 8998674)
21. Toxicities of drugs used in the management of fever.
Plaisance KI
Clin Infect Dis; 2000 Oct; 31 Suppl 5():S219-23. PubMed ID: 11113026
[TBL] [Abstract][Full Text] [Related]
22. [COX-2].
Oh-ishi S
Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1109-13. PubMed ID: 10771681
[No Abstract] [Full Text] [Related]
23. [COX-1 and COX-2: functions and pharmacological effects].
Hinz B; Brune K
Pharm Unserer Zeit; 1999 Jan; 28(1):21-9. PubMed ID: 10078026
[No Abstract] [Full Text] [Related]
24. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin endoperoxide synthetase isoenzymes: the clinical relevance of selective inhibition.
Frölich JC
Ann Rheum Dis; 1995 Dec; 54(12):942-3. PubMed ID: 8546523
[No Abstract] [Full Text] [Related]
26. COX-2 inhibitors--is there cause for concern?
Seibert K; Lefkowith J; Tripp C; Isakson P; Needleman P
Nat Med; 1999 Jun; 5(6):621-2. PubMed ID: 10371498
[No Abstract] [Full Text] [Related]
27. [NSAID and its effect on prostaglandin].
Toki M; Aoki K; Katsumi N; Takahashi S
Nihon Rinsho; 2007 Oct; 65(10):1807-11. PubMed ID: 17926528
[TBL] [Abstract][Full Text] [Related]
28. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
[No Abstract] [Full Text] [Related]
29. Aspirin and related nonsteroidal anti-inflammatory drugs as chemopreventive agents against colon cancer.
Marnett LJ
Prev Med; 1995 Mar; 24(2):103-6. PubMed ID: 7597006
[No Abstract] [Full Text] [Related]
30. Tempering the enthusiasm for COX-2 inhibitors.
Nuovo J
Am Fam Physician; 2000 Jun; 61(12):3560, 3563. PubMed ID: 10892630
[No Abstract] [Full Text] [Related]
31. [Current topics in the regulation of prostanoids-1. Inducible cyclooxygenase COX-2 and selective blockers].
Ohara M; Sawa T
Masui; 1998 Nov; 47(11):1325-32. PubMed ID: 9852696
[TBL] [Abstract][Full Text] [Related]
32. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.
Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F
Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006
[TBL] [Abstract][Full Text] [Related]
33. Experience with the particulate prostaglandin endoperoxide synthase assay for testing non-steroidal antiinflammatory drugs.
Schewe C; Ludwig P; Holzhütter HG; Schewe T
Pharmazie; 1991 Nov; 46(11):804-9. PubMed ID: 1811233
[TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?
Warner TD; Mitchell JA
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13371-3. PubMed ID: 12374850
[No Abstract] [Full Text] [Related]
35. Wolf in sheep's clothing?
Varga J
Am J Hosp Palliat Care; 2000; 17(4):280. PubMed ID: 11883807
[No Abstract] [Full Text] [Related]
36. [COX-2 specific inhibitors are similar--and different].
Aly A
Lakartidningen; 2000 Sep; 97(38):4181-2. PubMed ID: 11068393
[No Abstract] [Full Text] [Related]
37. The discovery and function of COX-2.
Needleman P; Isakson PC
J Rheumatol Suppl; 1997 Jul; 49():6-8. PubMed ID: 9249644
[No Abstract] [Full Text] [Related]
38. Re-classification of NSAIDs.
Griswold DE; Ruffolo RR; Poste G; Torphy TJ
Trends Pharmacol Sci; 1997 Sep; 18(9):311-2. PubMed ID: 9345847
[No Abstract] [Full Text] [Related]
39. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs.
Aspenberg P
J Orthop Res; 2004 May; 22(3):684; author reply 685. PubMed ID: 15099653
[No Abstract] [Full Text] [Related]
40. Inhibitors of cyclooxygenases: mechanisms, selectivity and uses.
Botting RM
J Physiol Pharmacol; 2006 Nov; 57 Suppl 5():113-24. PubMed ID: 17218763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
